AstraZeneca opens new global strategic R&D centre in Massachusetts, US

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kenda...

October 7, 2026 | Wednesday | News
Beyond Self-Reliance: BioJapan Turns 40 by Asking Japan to Orchestrate

Yokohama, 7 October 2026  |  BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokoham...

October 7, 2026 | Wednesday | News
Merck inks up to $2.13 B oncology deal with China's SciBrunch

Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered...

October 6, 2026 | Tuesday | News
Novartis signs licensing deal worth $7.2 B with China's Abogen for mRNA therapies

China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered...

October 7, 2026 | Wednesday | News
Taiwan's Energenesis Biomedical joins hands with Korea-based Yoo Young Pharm to develop treatment for diabetic foot ulcers

Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South K...

October 6, 2026 | Tuesday | News
Korea's SK pharmteco invests more than $200 M to expand small molecule and peptide capacity in US

SK pharmteco, a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea’s second-la...

October 6, 2026 | Tuesday | News
Qiagen expands AI-powered bioinformatics for research and drug discovery

Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and ge...

October 7, 2026 | Wednesday | News
Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M

Japanese startup Celaid Therapeutics Inc. has announced the completion of the second close of its Series B financing rou...

October 5, 2026 | Monday | News
Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment

Australia-based CSL and Swiss firm Alentis Therapeutics have entered into an exclusive global collaboration agreement to...

October 5, 2026 | Monday | News
Bayer to invest $2.2 B in new manufacturing site in US to create highly-skilled jobs

Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Bui...

October 3, 2026 | Saturday | News
China's Hengrui Pharma inks $2.6 B deal with Novo Nordisk for Once-Weekly oral GLP-1/GIP dual receptor agonist HRS-1596

China-based Hengrui Pharma has entered into a license agreement with Novo Nordisk for HRS-1596, a phase I-ready glucagon...

October 3, 2026 | Saturday | News
Toho, Reprocell partner for domestic distribution of regenerative medical product Stemchymal® in Japan

Reprocell Inc. has entered into a basic agreement with Toho Holdings toward a partnership concerning the domestic distri...

October 3, 2026 | Saturday | News
Korean govt expands market entry support for dermatology companies in Europe

The Ministry of Health and Welfare, South Korea government, has announced that it will open K-Beauty experience and reta...

September 30, 2026 | Wednesday | News
Chugai and InxMed enter into worldwide license agreement for RAF-MEK Molecular Glue

Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPY...

September 30, 2026 | Wednesday | News
Ontario contributes $1.7 M investment to advance life sciences innovation at Piramal Pharma's Aurora facility

Piramal Pharma Solutions (PPS), India-based Contract Development and Manufacturing Organization (CDMO) and part of Piram...

September 30, 2026 | Wednesday | News
Australia’s Telix Pharma receives US FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging

Australia-based Telix Pharmaceuticals has announced that the United States (US) Food and Drug Administration (FDA) has g...

September 30, 2026 | Wednesday | News
Korea's Lunit expands AI-powered breast cancer screening across Stockholm Region

South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that its ...

September 29, 2026 | Tuesday | News
Grünenthal partners with DKSH to bring four pain medicines to eight new markets in APAC

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthc...

September 29, 2026 | Tuesday | News
Singapore named GA4GH’s Asia-Pacific anchor for global genomics

Singapore is hosting the Global Alliance for Genomics and Health (GA4GH) 14th Plenary meeting from 28 September to 2 Oct...

September 29, 2026 | Tuesday | News
Thermo Fisher launches Gibco™ CHO-K1 Catalog Panel Media and Feed to accelerate biologics development

Thermo Fisher Scientific has announced the launch of Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal ...

September 28, 2026 | Monday | News
APEC’s Opportunity to Lead: Transforming Lung Cancer Outcomes Across Asia Pacific

As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they ...

September 28, 2026 | Monday | News
China's InnoCare inks $3.5 B deal with Eli Lilly to develop new medicines

InnoCare Pharma, a China-based biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, ha...

September 28, 2026 | Monday | News
Japan Agency for Medical Research and Development provides ¥2.8 B grant to United Immunity

United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, co...

September 28, 2026 | Monday | News
Neurology's Disease Modifying Moment

Neurology, once considered the graveyard of pharma development, is entering a new era. After years of high clinical fail...

October 1, 2026 | Thursday | Analysis
Approved, Coded, Listed: China’s neurotech speed run

On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, ...

October 1, 2026 | Thursday | Analysis